Which telehealth services still offer compounded GLP-1s after the FDA crackdown?

The landscape for compounded GLP-1s through telehealth services has significantly changed due to increased scrutiny and enforcement by the FDA, as well as actions taken by manufacturers like Novo Nordisk and Eli Lilly.

The FDA's stance has made it very difficult and risky for reputable telehealth services to offer compounded GLP-1s. The FDA's main concerns include:

1. Use of Unapproved Ingredients: Many compounded products used semaglutide sodium or tirzepatide acetate, which are not the active ingredients in the FDA-approved drugs (Ozempic, Wegovy, Mounjaro, Zepbound) and have not been tested for safety or efficacy in humans.
2. Lack of Shortage: Compounding is generally allowed only when there's a shortage of the FDA-approved drug product itself, not just the active pharmaceutical ingredient. The FDA has often stated that shortages of the finished products (like Ozempic or Wegovy) do not necessarily justify widespread compounding.
3. Safety and Quality Concerns: Compounded drugs do not undergo the same rigorous testing for safety, efficacy, and quality as FDA-approved medications. There have been reports of adverse events related to impure or improperly compounded products.

What This Means for Telehealth Services:

Most major, reputable telehealth platforms that provide weight management or diabetes care have largely ceased offering compounded GLP-1s in response to the FDA's crackdown and legal pressure. Their focus has shifted to facilitating prescriptions for the FDA-approved branded medications (Ozempic, Wegovy, Mounjaro, Zepbound), when medically appropriate and available.

Therefore, it is increasingly difficult, and often not advisable, to find telehealth services that still compliantly offer compounded GLP-1s. Any service claiming to do so should be scrutinized very carefully.

What you can still find through telehealth:

1. Prescriptions for Branded GLP-1s: Many telehealth platforms offer consultations, medical supervision, and prescriptions for the FDA-approved, brand-name GLP-1 medications (Ozempic, Wegovy, Mounjaro, Zepbound) if you meet the medical criteria. These services are legitimate, but availability and insurance coverage for these brand-name drugs can still be challenges.

   • Specific Brands/Services:
     • WeightWatchers Clinic (formerly Sequence): Offers medical consultations and prescriptions for FDA-approved GLP-1s, alongside comprehensive weight management programs.
     • Calibrate: Focuses on GLP-1s (primarily branded) combined with lifestyle coaching.
     • Found Health: Offers a combination of medication (including FDA-approved GLP-1s), coaching, and community support.
     • Ro (e.g., Ro Body): Provides consultations and prescriptions for FDA-approved weight loss medications, including GLP-1s.
     • PlushCare / Amwell / Sesame Care / Alpha: These general telehealth platforms can connect you with providers who may prescribe FDA-approved GLP-1s if clinically appropriate.

2. Very Limited, Highly Scrutinized Compounding (Buyer Beware!): A very small number of individual providers or pharmacies might claim to offer compounded GLP-1s, but this comes with significant caveats:

   • They would need to be sourcing pharmaceutical-grade semaglutide base (not salts) and compounding strictly according to federal and state pharmacy board regulations, and only if there is a documented shortage of the finished brand-name drug product.
   • It is incredibly challenging to verify this compliance, and the risks of receiving an unsafe or ineffective product are high.
   • I cannot recommend specific services in this category by name due to the high regulatory risk, lack of transparency, and potential for patient harm.

Recommendation:

If you are seeking GLP-1 medication for weight loss or diabetes management, prioritize your safety and efficacy:

• Seek out telehealth services that explicitly state they prescribe FDA-approved, brand-name GLP-1 medications. These are the safest and most reliable options.
• Be extremely wary of any service aggressively marketing "compounded GLP-1s" without clear, verifiable information about their sourcing, compounding pharmacy, and compliance with FDA guidelines. Ask very specific questions about the active ingredient (semaglutide base vs. salt), the specific compounding pharmacy used, and their rationale for compounding over prescribing an FDA-approved drug.
• Always consult with a licensed healthcare provider to determine the best and safest treatment plan for you.